Amrutanjan Health Care Share Price

NSE
AMRUTANJAN •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Amrutanjan Health Care
Amrutanjan Health Care Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Amrutanjan Health Care Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W Low today
3
Dividend yield 1yr %
Below industry Median
0.7

Amrutanjan Health Care shareholding Pattern

Promoter
46.5%
Foreign Institutions
2.3%
Mutual Funds
7.6%
Domestic Institutions
11.4%
Public
39.8%
Promoter
46.5%
Foreign Institutions
2.3%
Mutual Funds
9.2%
Domestic Institutions
11.1%
Public
40%
Promoter
46.5%
Foreign Institutions
2.3%
Mutual Funds
9.2%
Domestic Institutions
10.6%
Public
40.5%
Promoter
50.6%
Foreign Institutions
1.6%
Mutual Funds
6.8%
Domestic Institutions
7.3%
Public
40.5%
Promoter
50.6%
Foreign Institutions
1.4%
Mutual Funds
6.8%
Domestic Institutions
7.3%
Public
40.7%
Promoter
50.6%
Foreign Institutions
0.8%
Mutual Funds
6.8%
Domestic Institutions
7.2%
Public
41.2%

Amrutanjan Health Care Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
5Day EMA
678.40
10Day EMA
671.40
12Day EMA
668.90
20Day EMA
660.10
26Day EMA
655.40
50Day EMA
650.80
100Day EMA
665.00
200Day EMA
683.10
5Day SMA
673.10
10Day SMA
675.20
20Day SMA
658.90
30Day SMA
645.60
50Day SMA
629.20
100Day SMA
667.50
150Day SMA
693.20
200Day SMA
712.80
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
110880 Rs
243696 Rs
Week Rs
28304 Rs
60915 Rs
Month Rs
16334 Rs
43543 Rs
Resistance & Support
649.13
Pivot
Resistance
First Resistance
754.17
Second Resistance
814.03
Third Resistance
919.07
Support
First Support
589.27
Second support
484.23
Third Support
424.37
Relative Strength Index
61.75
Money Flow Index
60.35
MACD
13.46
MACD Signal
11.47
Average True Range
37.12
Average Directional Index
20.09
Rate of Change (21)
13.10
Rate of Change (125)
-3.82

Amrutanjan Health Care Latest News

29 APR 2025 | Tuesday

Amrutanjan Health Care Ltd-$ - 590006 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

07 APR 2025 | Monday

Amrutanjan Health Care Ltd-$ - 590006 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

26 MAR 2025 | Wednesday

Amrutanjan Health Care Ltd-$ - 590006 - Closure of Trading Window

View More

Amrutanjan Health Care Company background

Founded in: 1936
Managing director: S Sambhuprasad
Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennaibased Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on inhouse research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages hygiene and services in pain management.Amrutanjan has an agreement with a company in Philadelphia, US, to supply custommade chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 199697, it has introduced a new product called Cold Snap Gel and also a mint called tingle. Company having two subsidiary companies viz. Amrutanjan Drugs Chemicals Ltd having holding stake 99.80% Amrutanjan Finance Ltd, having holding stake is 57.26%.Company has taken efforts to increase the export of fine chemicals also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover net Profit of the Company.Diakyur for the treatment of Diabetes was introduced during 20002001. The name of Company changed from Amrutanjan Limited to Amrutanjan Health Care Limited during the year 200708. During the year 200910, the name of the Fine Chemicals Division of the Company was changed to Pharmaessense Chemistry Services Division.During April 2011 a new division under the name Amrutanjan Pain Management Center also known as CARE Specialized Pain Management Center was launched in Chennai. The Pharmaessense Chemistry Services Division was transferred to a wholly owned Subsidiary Company viz., Amrutanjan Pharmaessense Private Limited with all its assets and liabilities, excluding land during May 2011. Sivas Soft Drink Private Limited was acquired during February 2011 by way of transfer of shares. The Company launched Amrutanjan Headache Faster Relaxation Rollon 10ml SKU launched Amrutanjan Faster Relaxation Balm(white) during the year 201415.In FY 201617, the Subsidiary Company, Amrutanjan Pharmaessense Private Limited (Transferor Company) got merged with the Holding Company (M/s. Amrutanjan Health Care Limited/ Transferee Company), through Scheme of Amalgamation, effective from 1st July 2016. Accordingly, the assets and liabilities of Amrutanjan Pharmaessense Pvt Ltd as at 01st July, 2016 was taken over by the Company.Amrutanjan Comfy Snug Fit Sanitary napkin was launched in 201617. Comfy Snug Fit was launched in 2016. The New Maha Strong Pain Balm was relaunched in 2016. Orange variant was launched in addition to existing Apple variant during financial year 201819. The flavour Alphonso, the King of Mangoes, was launched in 200 ml Ready to drink recyclable PET format. Two more new variants, Comfy XLand Comfy Ultra were launched during 201920. The Company relaunched its headache Pain balm in 202122. It introduced Amrutanjan Comfy Sung Fit Regular Cottony in FY22. A new product, Amrutanjan Stop Pain Dental Gel was launched for Oral Health Care in 2023. In FY 2024, it launched Pain cream and Electro Plus Lemon and Lowsugar variants.
Read More

Amrutanjan Health Care FAQs

Amrutanjan Health Care share price is ₹700 in NSE and ₹692.8 in BSE as on 30/4/2025.

Amrutanjan Health Care share price in the past 1-year return was -0.62. The Amrutanjan Health Care share hit a 1-year low of Rs. 544.1 and a 1-year high of Rs. 862.6.

The market cap of Amrutanjan Health Care is Rs. 2007.27 Cr. as of 30/4/2025.

The PE ratios of Amrutanjan Health Care is 40.61 as of 30/4/2025.

The PB ratios of Amrutanjan Health Care is 6.72 as of 30/4/2025

The Mutual Fund Shareholding in Amrutanjan Health Care was 7.55% at the end of 30/4/2025.

You can easily buy Amrutanjan Health Care shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Amrutanjan Health Care stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -